Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Simes

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|February 22, 2021
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based studyMonica Tang, Andrea L Schaffer, Belinda E Kiely, et al.
International Journal of Obesity (2005)|December 4, 2008
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID studyS Söderberg, D Colquhoun, A Keech, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancerMonica Tang, Chee K Lee, Craig R Lewis, et al.
BMJ (Clinical Research Ed.)|June 27, 1992
Cholesterol and total mortality: need for larger trialsR Collins, A Keech, R Peto, et al.
Lancet (London, England)|May 22, 2012
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, B Mihaylova, J Emberson, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?V M Duric, M R Stockler, S Heritier, et al.
Journal of the American College of Cardiology|July 14, 2001
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study InvestigatorsI C Marschner, D Colquhoun, R J Simes, et al.
Breast Cancer Research and Treatment|March 30, 2011
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerC K Lee, M Hudson, M Stockler, et al.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|February 22, 2021
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based studyMonica Tang, Andrea L Schaffer, Belinda E Kiely, et al.
International Journal of Obesity (2005)|December 4, 2008
Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID studyS Söderberg, D Colquhoun, A Keech, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2022
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancerMonica Tang, Chee K Lee, Craig R Lewis, et al.
BMJ (Clinical Research Ed.)|June 27, 1992
Cholesterol and total mortality: need for larger trialsR Collins, A Keech, R Peto, et al.
Lancet (London, England)|May 22, 2012
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, B Mihaylova, J Emberson, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2005
Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?V M Duric, M R Stockler, S Heritier, et al.
Journal of the American College of Cardiology|July 14, 2001
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study InvestigatorsI C Marschner, D Colquhoun, R J Simes, et al.
Breast Cancer Research and Treatment|March 30, 2011
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerC K Lee, M Hudson, M Stockler, et al.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
Pageof 15